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OBJECTIVES The aim of our study was to evaluate the volume-outcome relationship in a large,
quality-controlled, contemporary percutaneous coronary interventions (PCI) database.
BACKGROUND Whether the relationship between physician volume of PCI and outcomes still exists in the
era of coronary stents is unclear.
METHODS Data on 18,504 consecutive PCIs performed by 165 operators in calendar year 2002 were
prospectively collected in a regional consortium. Operators’ volume was divided into quintiles
(1 to 33, 34 to 89, 90 to 139, 140 to 206, and 207 to 582 procedures/year). The primary end
point was a composite of major adverse cardiovascular events (MACE) including death,
coronary artery bypass grafting, stroke or transient ischemic attack, myocardial infarction, and
repeat PCI at the same site during the index hospital stay.
RESULTS The unadjusted MACE rate was significantly higher in quintiles one and two of operator
volume when compared with quintile five (7.38% and 6.13% vs. 4.15%, p  0.002 and p 
0.0001, respectively). A similar trend was observed for in-hospital death. After adjustment for
comorbidities, patients treated by low volume operators had a 63% increased odds of MACE
(adjusted odds ratio [OR] 1.63, 95% confidence interval [CI] 1.29 to 2.06, p  0.0001 for
quintile [Q]1; adjusted OR 1.63, 95% CI 1.34 to 1.90, p  0.0001 for Q2 vs. Q5), but not
of in-hospital death. Overall, high volume operators had better outcomes than low volume
operators in low-risk and high-risk patients.
CONCLUSIONS Although the relationship between operator volume and in-hospital mortality is no longer
significant, the relationship between volume and any adverse outcome is still present.
Technological advancements have not yet completely offset the influence of procedural
volume on proficiency of PCIs. (J Am Coll Cardiol 2005;46:625–32) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.048American College of Cardiology Foundation
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brior studies have shown a relationship between physician
olume and outcomes of percutaneous coronary intervention
PCI), with better outcomes reported for high volume
perators when compared with low volume operators. These
ata have lead to the wide acceptance of volume standards as
quality indicator for PCI. (1) Many of these studies,
owever, were performed through analysis of claims data
2,3) or of data collected in a time period preceding the
idespread use of coronary stents and glycoprotein IIb/IIIa
eceptor blockers in clinical practice (4). Thus, whether the
From the *Division of Cardiology, University of Michigan Medical Center; ‡St.
oseph Mercy Hospital, Ann Arbor, Michigan; †Blue Cross Blue Shield of Michigan;
St. John’s Hospital and Medical Center, Detroit, Michigan; §Oakwood Hospital,
earborn, Michigan; Spectrum Health, Grand Rapids, Michigan; #McLaren
egional Medical Center, Flint, Michigan; **St. Joseph Hospital, Pontiac, Michigan;
†Ingham Regional Medical Center, Lansing, Michigan; and the ‡‡Sparrow Medical
enter, Lansing, Michigan. Supported by an unrestricted grant from Blue Cross Blue
hield of Michigan (Detroit, Michigan).a
Manuscript received September 24, 2004; revised manuscript received May 10,
005, accepted May 22, 2005.elationship between operator volume and outcomes still
xists in the era of contemporary PCI is not as well
stablished. The objective of our study was to evaluate the
olume-outcome relationship with contemporary PCI with
large, quality-controlled regional clinical database. A
econdary objective was to determine whether the American
ollege of Cardiology (ACC) volume guidelines of a
inimum of 75 procedures/year still apply to contemporary
CI practice (1).
ETHODS
linical, procedural, and outcome data on 18,504 consecu-
ive PCIs were prospectively collected in 14 hospitals in
ichigan in the calendar year 2002. Data were collected
ith a standardized data collection form and standardized
efinitions. The University of Michigan institutional review
oard and local review boards in each participating center
pproved this study. After several meetings for identification
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Operator Volume and Outcomes With Contemporary PCI August 16, 2005:625–32f data elements to be collected and defined, a dictionary
ith standard definitions was prepared by the coordinating
enter and distributed to the participating hospitals. Each
ospital agreed to allocate a dedicated staff member to the
oordination and quality assurance of data collection. All
ata forms were processed by the coordinating center and
ndividually evaluated for face validity and completeness.
ncomplete forms were recorded by the participating hos-
itals and resubmitted to the coordinating center. After
ompletion of the initial data quality assurance process, site
isits were performed by the coordinating center, and a
rained nurse investigator from one of the other participat-
ng hospitals performed a site visit to the coordinating
enter. During the site visits, cardiac catheterization logs
ere compared with the database logs to ensure enrollment
f every patient treated during the time-period in question.
he medical records of patients who died in the hospital or
ho underwent coronary artery bypass surgery were re-
iewed and compared with the form submitted to ensure
ccuracy of end points and key comorbidities. In addition,
% of cases were randomly selected for comprehensive audit
ith review of the medical record by a trained nurse
nvestigator. The results of the data audits for major
utcomes performed during the site visits revealed 0%
issing death, 0% missing stroke or transient ischemic
ttack, 0% missing coronary artery bypass grafting (CABG)
uring the same hospital stay, 0% missing post-procedure
-wave myocardial infarctions (MIs), a 0.5% missing rate
f clinically significant non–Q-wave MI, and 0.78% missing
ases. All missing cases were re-coded and entered in the
atabase.
Coronary artery stenoses were classified with the modi-
ed ACC/American Heart Association (AHA) lesion clas-
ification. In addition, angiographic characteristics, includ-
ng the presence of visible thrombus and of moderate or
eavy calcification, were collected for each lesion.
perator volume. A total of 165 operators performing
CI on 18,504 patients during the full calendar year 2002
ere included in this analysis. All participating institutions
ollected operator volume data as part of their own quality
ssurance program. The volume data collected included
rocedures performed in the specific institution and in other
nstitutions. In the registry, to ensure operator confidenti-
Abbreviations and Acronyms
ACC  American College of Cardiology
AHA  American Heart Association
CABG  coronary artery bypass grafting
CI  confidence interval
MACE  major adverse cardiovascular events
MI  myocardial infarction
PCI  percutaneous coronary intervention
Q  quintilelity, each operator is assigned a code number by the fubmitting institution. Therefore, to ensure accuracy in the
ssigned volume variable—particularly for operators who
ight have been performing procedures in more than one
nstitution—for each operator, the annual procedure volume
n the registry was confirmed against the procedure volume
rovided by the hospital administration of each institution.
Operators were grouped by quintile (Q) according to the
umber of procedures performed as follows: the first quin-
ile included operators performing 1 to 33 PCI/year (393 or
.2% of total procedures), the second quintile included
perators performing 34 to 89 PCI/year (2,105 or 11.4% of
otal procedures), the third quintile included operators
erforming 90 to 139 PCI/year (3,117 or 16.8% of total
rocedures), the fourth quintile included operators perform-
ng 140 to 206 procedures/year (5,134 or 27.9% of total
rocedures), and the fifth quintile included operators per-
orming 207 to 582 procedures/year (7,755 or 41.9% of total
rocedures). The ACC and AHA currently recommend a
inimum of 75 PCI/year per operator (1). Therefore, a
econdary analysis was performed with the 75 PCI/year as a
utoff to differentiate “low volume operators” from “high
olume operators.”
issing data. Baseline demographics (including age and
ender), comorbidities, procedure, and outcome data were
ecorded in every case. Among the other data elements,
aseline creatinine and ejection fraction were missing in
.7% and 19.7% of cases, respectively. Missing values for
reatinine were coded as 1.5 mg/dl, whereas missing
alues for the ejection fraction were imputed with a linear
egression model, including age, left ventricular end dia-
tolic pressure, cardiogenic shock, history of prior CABG,
istory of prior MI, gender, and history of congestive heart
ailure (5–7).
linical end point. The primary end point was a compos-
te of major adverse cardiovascular events (MACE), includ-
ng in-hospital death, CABG surgery, stroke or transient
schemic attack, MI, and repeat PCI at the same site during
he index hospital stay. The secondary end point was
n-hospital death.
tatistical analysis. Data are expressed as mean  stan-
ard deviation or as percentage. Analysis of variance was
sed for differences between means, and Pearson chi-square
est was used for differences in frequencies. Trends across
uintile of procedure volume were evaluated with the
ochran-Armitage trend test for significance.
Independent predictors of in-hospital mortality and
ACE were determined by stepwise multivariate logistic
egression analysis. Those variables with p value 0.2 in
nivariate analysis were included in stepwise regression
rocedures for MACE and for in-hospital mortality. The
ollowing variables were evaluated in the stepwise regression
rocess: age, gender, hypertension, diabetes mellitus, extra-
ardiac vascular disease (defined as any history of peripheral
ascular disease or stroke), congestive heart failure, renal
ailure requiring dialysis, gastro-intestinal bleeding, chronic
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August 16, 2005:625–32 Operator Volume and Outcomes With Contemporary PCIbstructive pulmonary disease, atrial fibrillation, history of
ardiac arrest, prior history of percutaneous intervention,
rior history of coronary artery bypass surgery, creatinine
1.5 mg/dl, MI within 7 days, MI within 24 h, cardiac
rrest, prior thrombolysis, cardiogenic shock, ventricular
achycardia or fibrillation in the setting of acute MI,
mergency angioplasty, rescue angioplasty after failed
hrombolysis, unstable angina (requiring intravenous ni-
roglycerin and heparin treatment), number of diseased
essels (70% stenosis), left ventricular ejection fraction
50%, ACC type C stenosis, visible thrombus on the
nitial coronary angiogram, prior history of MI, left main
tenosis (70%), anemia (hemoglobin 10 g/dl), and the
resence of moderate or heavy calcification. Model dis-
rimination was assessed with the c-statistic, and good-
ess of fit was assessed with the Hosmer-Lemeshow
tatistics. Three groups of models were fitted. In the first
roup, hospitals were considered as fixed effects; in the
econd group, a random effect was included, assuming
ormal hospital-effect distributions; and in the third
able 1. Clinical and Procedural Characteristics According to Qu
Quintile 1 Quint
1–33†
(n  393)
34–8
(n  2
33‡ 34‡
n (%) n (%
emographics
Age mean ( SD) 63.2 (13.3) 64.1 (
Female gender 150 (38.2) 770 (
Smoking 108 (27.5) 526 (
istorical
CHF 49 (12.5) 258 (
Hypertension 276 (70.2) 1,607 (
ECVD 70 (17.8) 420 (
Diabetes 102 (26.0) 640 (
Renal failure on dialysis 9 (2.3) 32 (
MI 132 (33.6) 701 (
CABG 66 (16.8) 400 (
PCI 142 (36.1) 724 (
linical presentation at time of PCI
Ejection fraction mean ( SD) 52.8 (11.6) 52.2 (
Creatinine 1.5 mg/dl 42 (10.7) 235 (
Creatinine 2.0 mg/dl 13 (3.3) 71 (
MI within 24 h 101 (25.7) 335 (
Rescue PCI 21 (5.3) 61 (
Cardiogenic shock 8 (2.0) 56 (
Cardiac arrest 23 (5.9) 149 (
rocedural characteristics
Three vessel disease (70%) 87 (22.1) 428 (
Thrombus 70 (17.8) 456 (
Type C lesion 78 (19.9) 409 (
Severe calcification 70 (17.8) 580 (
MCD exceeded 50 (14.1) 186 (
Stent 313 (80.5) 1,694 (
Glycoprotein IIb/IIIa blockers 309 (78.6) 1,666 (
Total contrast/case (ml), mean ( SD) 233 (103.2) 214 (
p values are from the Pearson chi-square test for categorical variables and from analy
f operators.
CABG  coronary artery bypass grafting; CHF  congestive heart failure; ECV
djusted maximum contrast dose calculated using the formula: body weight in kg  5 cc/
ntervention.roup, generalized estimating equations were fitted to
ontrol for clustering and variation by hospital (8).
tandardized event ratios (observed/predicted) and 95%
onfidence intervals were also calculated (9).
A prior study has suggested that low volume of proce-
ures (coronary artery bypass surgery) might be a negative
orrelate of worse outcomes in high-risk patients, but not in
ow-risk patients (10); however, a more recent study has
hown that the relationship between operator volume and
utcomes might be independent of patients’ risk (11). To
xplore this potential relationship further, predicted proba-
ilities of MACE for individual patients were calculated.
atients were stratified in quartiles of predicted risk of
ACE, and observed and predicted rates of MACE were
hen calculated according to the quintile of operator volume.
n additional analysis was performed by dividing proce-
ures according to the day of the week (weekend vs.
eekday).
Statistical analysis was performed with SAS version 8.2
SAS Institute, Cary, North Carolina).
e of Operator Volume
Quintile 3 Quintile 4 Quintile 5
p Value*
90–139†
(n  3,117)
140–206†
(n  5,134)
207–582†
(n  7,755)
32‡ 34‡ 32‡
n (%) n (%) n (%)
63.7 (12.3) 63.5 (12.2) 63.8 (12.2) 0.32
1,064 (34.1) 1,774 (34.6) 2,625 (33.9) 0.09
769 (24.7) 1,346 (26.2) 2,038 (26.3) 0.32
380 (12.2) 479 (9.3) 926 (11.9) 0.0001
2,277 (73.1) 3,737 (72.8) 5,574 (71.9) 0.001
565 (18.1) 985 (19.2) 1,707 (22.0) 0.0001
964 (30.9) 1,608 (31.3) 2,333 (30.1) 0.17
42 (1.4) 48 (0.9) 104 (1.3) 0.05
1,055 (33.9) 1,692 (33.0) 2,736 (35.3) 0.07
567 (18.2) 1,053 (20.5) 1,667 (21.5) 0.0004
1,146 (36.7) 2,015 (39.3) 3,112 (40.1) 0.0001
52.7 (12.1) 52.3 (11.3) 52.3 (11.9) 0.37
338 (10.8) 510 (9.9) 754 (9.7) 0.20
110 (3.5) 179 (3.5) 250 (3.2) 0.91
572 (18.4) 880 (17.1) 1,244 (16.0) 0.0001
126 (4.0) 175 (3.4) 255 (3.3) 0.04
85 (2.7) 100 (2.0) 173 (2.2) 0.14
174 (5.6) 270 (5.3) 404 (5.2) 0.02
596 (19.1) 1,021 (19.9) 1,693 (21.8) 0.009
541 (17.4) 634 (12.4) 1,405 (18.1) 0.0001
587 (18.8) 1,107 (21.6) 1,737 (22.4) 0.0002
749 (24.0) 1,156 (22.5) 1,288 (16.6) 0.0001
300 (10.7) 350 (7.9) 528 (7.7) 0.0001
2.541 (82.7) 4,102 (81.3) 6,288 (81.8) 0.44
2.597 (83.3) 4,048 (78.9) 5,249 (67.9) 0.0001
230 (99.2) 208 (93.3) 207 (103.2) 0.0001
ariance for continuous variables. †Qualifying yearly number of procedures. ‡Number
extra-cardiac vascular disease; MCD exceeded  exceeding a weight and creatinineintil
ile 2
9†
,105)
)
12.2)
36.6)
25.0)
12.3)
76.3)
20.0)
30.4)
1.5)
33.3)
19.0)
34.4)
11.7)
11.2)
3.4)
15.9)
2.9)
2.7)
7.1)
20.3)
21.7)
19.4)
27.6)
9.6)
81.0)
79.1)
90.4)
sis of v
D 
serum creatinine (21); MI  myocardial infarction; PCI  percutaneous coronary
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Operator Volume and Outcomes With Contemporary PCI August 16, 2005:625–32ESULTS
aseline clinical characteristics are shown in Table 1.
ompared with patients treated in the other quintiles,
atients treated in the lowest volume quintiles (Q1 and Q2)
ad similar rates of historical risk factors. Compared with
he other quintiles, the first quintile had a higher percentage
f patients undergoing PCI within 24 h from an MI.
ignificant variation was observed in the reported frequency
f visible thrombus and severe calcification on the initial
ngiogram, whereas the frequency of type C lesions was
ignificantly higher in the high volume quintiles (Q4 and
5). No significant differences were observed in the fre-
uency of coronary stenting, although significant practice
ariation was observed across the five volume quintiles in the
se of glycoprotein receptor blockers, with the lowest use in
atients treated by high volume operators (Table 1). Base-
ine demographic data and procedure variables in the two
roups of patients, stratified according to the 75-
rocedure/year criterion of operator volume, are shown in
able 2.
linical outcomes. The unadjusted MACE rate was sig-
ificantly higher in the group of patients treated by low
Table 2. Clinical and Procedural Characteristic
75 Procedures/Year and in Patients Treated
Demographics
Age mean ( SD)
Female gender
Smoking
Historical
CHF
Hypertension
ECVD
Diabetes
Renal failure on dialysis
MI
CABG
PCI
Clinical presentation at time of PCI
Ejection fraction mean ( SD)
Creatine 1.5 mg/dl
Creatine 2.0 mg/dl
MI within 24 h
Rescue PCI
Cardiogenic shock
Cardiac arrest
Procedural characteristics
Three vessel disease
Thrombus
Type C lesion
Severe calcification
MCD exceeded
Stent
Glycoprotein IIb/IIIa blockers
Total contrast/case (ml), mean ( SD)*Number of operators.
All abbreviations as in Table 1olume operators (Q1 and Q2) when compared with the
roup of patients treated by high volume operators (Q5)
7.38% and 6.13% vs. 4.15%, p  0.002 and p  0.0001,
espectively) (Table 3). The higher MACE rate in the
owest quintiles was associated with a trend toward higher
ates of each individual component of the combined end
oint, including death in the hospital, MI, stroke, need of
oronary artery bypass surgery, and repeat PCI of the same
ite, and with higher rates of contrast nephropathy and
lood transfusion. The higher rate of contrast nephropathy
as associated with a higher amount of contrast media/case
Table 1) and with a higher frequency of exceeding a weight
nd creatinine-adjusted maximum contrast dose (12). After
djustment for comorbidities, patients treated by low vol-
me operators had 63% increased odds of MACE (adjusted
R 1.63, 95% CI 1.29 to 2.06, p  0.0001 for Q1 vs. Q5;
djusted OR 1.63, 95% CI 1.34 to 1.90, p  0.0001 for Q2
s. Q5) (generalized estimating equation modeling) (Fig. 1).
he same results were observed when modeling was per-
ormed with fixed effect or random effect modeling. After
djustment for comorbidities and clinical presentation,
owever, there was no significant relationship between low
Patients Treated by Operator Performing
perator Performing 75 Procedures/Year
Volume
1,440)
>75 Volume
(n  17,064)
p Value
4* 111*
(%) n (%)
(12.5) 63.7 (12.2) 0.73
(38.1) 5,834 (34.2) 0.003
(26.2) 4,410 (25.8) 0.78
(12.0) 1,919 (11.3) 0.38
(74.3) 12,401 (72.7) 0.18
(18.9) 3,475 (20.4) 0.18
(28.9) 5,231 (30.7) 0.16
(1.5) 213 (1.3) 0.36
(34.2) 5,824 (34.1) 0.98
(20.2) 3,462 (20.3) 0.94
(35.2) 6,631 (38.9) 0.006
(11.3) 52.4 (11.8) 0.65
(10.1) 1,734 (10.2) 0.91
(3.4) 574 (3.4) 0.94
(18.5) 2,865 (16.8) 0.09
(2.7) 599 (3.5) 0.11
(2.5) 386 (2.3) 0.56
(7.8) 908 (5.3) 0.0001
(20.4) 3,531 (20.7) 0.80
(19.3) 2,828 (16.6) 0.008
(17.4) 3,667 (21.5) 0.0003
(23.3) 3,507 (20.6) 0.01
(9.8) 1,284 (8.5) 0.10
(80.1) 13,791 (81.8) 0.10
(74.5) 12,796 (75.0) 0.69
(95.6) 212 (99.1) 0.27s in
by O
<75
(n 
5
n
63.9
549
377
173
1,070
272
416
22
492
291
507
52.2
145
49
267
39
36
112
294
278
251
336
130
1,147
1,073
215
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August 16, 2005:625–32 Operator Volume and Outcomes With Contemporary PCIperator volume and risk of death in the hospital (adjusted
R for Q1 0.97, 95% CI 0.53 to 1.77, p  0.92; adjusted
R for Q2 1.09, 95% CI 0.69 to 1.73, p  0.70).
The results of the analysis of operator volume according
o the standards recommended by the ACC/AHA Guide-
ines (75 PCI/year per operator) are shown in Table 4.
fter adjustment for comorbidities, no significant differ-
nces in MACE and mortality were observed in the group
f patients treated by operators performing 75 PCI/year
hen compared with the group of patients treated by
perators performing75 PCI/year (adjusted OR for death
.81, 95% CI 0.47 to 1.41, p  0.46; adjusted OR for
ACE 1.05, 95% CI 0.83 to 1.32, p  0.67). This lack of
ifference was due to the inclusion in the high volume group
75 procedures/year) of operators classified as “low vol-
me” in the quintile analysis, and to pooling all operators in
nly two groups; however, when data were analyzed accord-
igure 1. Adjusted odds ratios (OR) for major adverse cardiovascular event
n the final model were: quintiles one to four, age, gender, history of con
xtra-cardiac vascular disease, history of chronic obstructive pulmonary d
raction 50%, American College of Cardiology type C lesion, left main
able 3. Unadjusted Outcomes by Quintile of Operator Volume
Quintile 1 Quintile 2
Peri-Procedural
Outcome
1–33†
(n  393)
34–89†
(n  2,105)
n (%) n (%)
ontrast nephropathy‡ 17 (4.33) 94 (4.47)
ascular complications 15 (3.82) 57 (2.71)
ransfusion 34 (8.65) 150 (7.13)
eath 8 (2.04) 35 (1.66)
I 6 (1.53) 32 (1.52)
troke or TIA 0 (0) 11 (0.52)
mergency CABG 3 (0.76) 25 (1.19)
ll CABG 10 (2.54) 56 (2.66)
epeat PCI (same site) 6 (1.53) 13 (0.62)
ACE§ 29 (7.38) 129 (6.13)
p values are from the Pearson chi-square test. †Qualifying yearly number of procedu
g/dl over baseline. §Major adverse cardiovascular events: death, MI, stroke or tran
Abbreviations as in Table 1.oronary angiogram, cardiac arrest, acute myocardial infarction (MI), MI within
n the setting of acute MI, and unstable angina. C statistic  0.82. Hosmer-Lng to the day of the week (weekends vs. weekdays),
ignificant differences emerged. The unadjusted “weekend”
ACE rate for operators performing 75 procedures/year
as 15.79%, compared with a MACE rate of 8.45% for
perators performing 75 procedures/year (p  0.01); week-
ay mace rates were 3.85% and 4.32%, respectively (p 0.41).
elationship between operator volume and patients’ risk.
igure 2 shows predicted and observed MACE rates in
atients stratified by quartile of risk, with further stratifica-
ion by quintile of operator volume. Overall, high volume
perators had better outcomes than low volume operators in
oth low-risk and high-risk patients, with the highest
ifference observed in high-risk patients. In addition, when
he analysis was limited to patients undergoing either
alloon angioplasty or stenting in native coronary arteries
nly—thus, with the exclusion of other devices and of PCI
n vein grafts—higher MACE rates were still observed in
generalized estimating equations clustering modeling. Variables included
e heart failure, history of prior coronary artery bypass grafting, history of
e, emergency procedure, creatinine 1.5 mg/dl, left ventricular ejection
sis (70%), three-vessel disease (70%), visible thrombus on the initial
intile 3 Quintile 4 Quintile 5
p Value*
0–139†
 3,117)
140–206†
(n  5,134)
207–582†
(n  7,755)
n (%) n (%) n (%)
6 (3.72) 149 (2.90) 256 (3.30) 0.01
8 (2.18) 142 (2.77) 190 (2.45) 0.22
8 (5.71) 272 (5.30) 387 (4.99) 0.0001
7 (1.51) 57 (1.11) 110 (1.42) 0.23
5 (1.44) 70 (1.36) 100 (1.29) 0.92
4 (0.45) 18 (0.35) 24 (0.31) 0.38
9 (0.61) 15 (0.29) 20 (0.26) 0.0001
6 (1.48) 60 (1.17) 67 (0.86) 0.0001
5 (0.80) 35 (0.68) 59 (0.76) 0.39
5 (4.97) 213 (4.15) 322 (4.15) 0.0001
ontrast nephropathy is defined as increase in post-procedure serum creatinine 0.5
schemic attack (TIA), CABG, and repeat PCI (same site).s with
gestiv
iseas
stenoQu
9
(n
11
6
17
4
4
1
1
4
2
15
res. ‡C7 days, cardiogenic shock, ventricular tachycardia or ventricular fibrillation
emeshow chi-square  2.9, p  0.94. CI  confidence interval.
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Operator Volume and Outcomes With Contemporary PCI August 16, 2005:625–32atients treated by low volume operators (6.4% and 6.0% for
1 and Q2, respectively, vs. 3.9% for Q5, p  0.0001).
ariability among operators. To further determine poten-
ial differences in the rates of adverse outcomes, standard-
zed MACE ratios (observed/predicted) for each individual
perator were plotted against the individual operator annual
olume. As shown in Figure 3, there was a continuous
elationship between operator volume and outcomes, with
ower standardized ratios observed with high volume oper-
tors; however, there was also significant variation, as shown
y the presence of some low volume operators with better-
han-expected outcomes (standardized ratio 1), and of a
able 4. Unadjusted Outcomes by Operator Volume According
o the 75 Procedures/Year Definition
<75 Volume
(n  1,440)
>75 Volume
(n  17,064)
p Valuen (%) n (%)
ontrast nephropathy* 56 (3.89) 576 (3.38) 0.30
ascular complications 41 (2.85) 431 (2.53) 0.46
ransfusion 94 (6.53) 927 (5.43) 0.08
eath 19 (1.32) 238 (1.39) 0.81
I 16 (1.11) 237 (1.39) 0.38
troke 2 (0.14) 65 (0.38) 0.14
mergency CABG 12 (0.83) 70 (0.41) 0.02
ll CABG 27 (1.88) 212 (1.24) 0.04
epeat PCI (same site) 10 (0.69) 128 (0.75) 0.81
ACE† 69 (4.79) 779 (4.57) 0.69
Contrast nephropathy is defined as increase in post-procedure serum creatinine0.5
g/dl over baseline. †Major adverse cardiovascular events: death, MI, stroke
mergency CABG, and repeat PCI (same site).
Abbreviations as in Table 1.igure 2. Relationship between operator volume and patients’ risk. Predicted and
y quartile of risk, with further stratification by quintile of operator volume. Qmall number of high volume operators with worse-than-
xpected outcomes (standardized ratio 1).
ISCUSSION
n this study, we analyzed the volume-outcome relationship
n a large contemporary quality controlled multicenter
egistry of PCI. We found that, after adjustment for
omorbidities and other confounders, low procedure volume
ontinues to be a predictor of worse outcomes (MACE),
nd this relationship appears to be relatively independent of
he patients’ risk. In addition, we found that the volume
hreshold might be higher than the threshold of 75 proce-
ures/year suggested by the ACC/AHA guidelines. We
ere not able to show a relationship between low operator
olume and risk of death.
The relationship between low procedure volume and adverse
utcomes has been previously shown for PCI, for coronary
rtery bypass surgery and more recently, for other surgical
ardiovascular and cancer resection procedures (13,14). Al-
hough the continued importance of this relationship for
oronary artery bypass surgery was recently confirmed with
ontemporary clinical data (15), for PCI, the majority of the
tudies available either predate the widespread introduction in
nterventional practice of coronary stenting and of glycoprotein
eceptor blockers or was obtained through analysis of Medicare
laims data. Recognized limitations related to analysis of
edicare data include the need to extrapolate total number of
rocedures from the number of Medicare procedures, the often
ncomplete reporting in Medicare claims of comorbidities thatobserved major adverse cardiovascular events (MACE) rates are stratified
 quintile (i.e., Q1, Q2, Q3, Q4, and Q5).
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utcomes (14,16), and the potential for miscoding of compli-
ations as comorbidities (17).
Ellis et al. (18) analyzed clinical data from a quality-
ontrolled, clinical, multi-institutional database of PCIs.
he patient population included patients treated during
alendar year 1993 and 1994, a time-period predating the
idespread use of coronary stents and of glycoprotein
Ib/IIIa receptor blockers. They found that operators per-
orming 70 procedures per year had significantly worse
utcomes than the remainder of the group. In addition, the
est outcomes were observed in a high volume group of
perators performing 270 procedures per year. Similar
esults were reported by Hannan et al. (19) in an analysis of
ata from the New York State Department of Health
oronary Angioplasty Reporting System obtained between
anuary 1, 1991, and December 31, 1994 and by Jollis et al.
2,3) in two separate analyses of claim data from the
edicare database. Both analyses also predated the wide-
pread introduction of coronary stents and of glycoprotein
Ib/IIIa receptor blockers in interventional practice, and
oth reports showed better outcomes with high volume
perators, including lower mortality rates. More, recently,
cGrath et al. (20) analyzed relatively contemporary data
calendar year 1997) from the Medicare database. Given
hat Medicare patients represent 35% to 45% of total PCI
rocedure volume, they estimated that 30 PCI per operator
er year on Medicare patients could be extrapolated to a
otal procedure volume of 70 PCI per operator per year.
tent use was 50.6% for operators performing 30 Medi-
are PCI/year and 61.1% for operator performing 60
edicare PCI/year. A significant relationship between op-
rator volume and outcomes was also reported in their
tudy, with better outcomes observed in patients treated by
igh volume operators when compared with patients treated
y low volume operators.
Figure 3. Linear plot of standardized major adverse cardiovascular evenOur results are at odds, however, with a report from the worthern New England Cardiovascular study group with
ata from 1994 through 1996 and using a similar sample
ize and methodology. In that study, no significant relation-
hip was found between annual operator procedure volume
nd outcomes (21). Whether this discrepancy indicates that
he results of this type of analysis cannot be generalized
emains to be determined.
The ACC and AHA currently recommend a minimum
f 75 PCI/year per operator. In our analysis, we were not
ble to confirm a relationship between operator volume and
utcomes when this cutoff was used. The analysis of volume,
y quintile and by individual operator, suggested that this
nding was due to the inclusion in the high volume group
75 procedures/year) of operators classified as “low vol-
me” in the quintile analysis and to pooling all operators in
nly two groups. In addition, significant variability in
linical outcomes was observed in the low volume group.
Our analysis of contemporary practice supports the hy-
othesis that technological advancements have not yet
ompletely offset the influence of procedural volume in
etermining proficiency of contemporary PCIs. Whereas
he relationship between operator volume and in-hospital
ortality is no longer significant, the relationship between
olume and any major adverse outcome is still present. In
ddition, this relationship appears to be relatively indepen-
ent of patient-specific risk, thus suggesting that it remains
o be determined whether it can be further offset by
eticulous risk stratification and case selection. Although
rocedure volume is only a poor surrogate of quality and
utcomes, and it should not be used as a replacement for
ppropriately risk-adjusted outcomes, annual procedure vol-
me is clear and easily understandable information for
atients undergoing PCI. Thus, it seems appropriate to
ontinue to include operator procedure volume among the
everal quality indicators of contemporary PCI practice,
ACE) ratios (observed/predicted rates) versus annual operator volume.ith the understanding that, as of today, its value is not as
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or blockers era.
Our study has several limitations. All the hospitals
articipating in the consortium were relatively high volume
nstitutions performing 644 procedures/year, and there-
ore, we could not evaluate the interaction between low
olume institutions (400 procedures/year) and low volume
perators. Biomarkers of myocardial necrosis after the
rocedure were not obtained on a routine basis in all
atients, but were rather obtained when it was felt indicated
y the physicians in charge of post-procedure care. Further
nalysis (data not shown) revealed no changes in the results,
owever, when post-procedure MI was excluded from the
ombined outcome (MACE) variable. Low volume opera-
ors appeared to have a higher case-mix of difficult cases—
esions with higher frequency of visible thrombus or calci-
cation—but a lower frequency of type C lesions. We could
ot determine whether these differences were due to a
ifferent case-mix or to a different interpretation of the
oronary angiograms. Although the risk adjustment model
ccounted for these differences, we cannot exclude that we
ere unable to adjust fully for these differences.
We were also unable to determine the potential effect of
oard certification or of number of years in practice,
perator-specific characteristics that might offset the influ-
nce of volume. In addition, since we only analyzed data
rom a regional consortium, our results should not neces-
arily be generalized to other regions of the nation or of the
orld.
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